About this trial
Vaginal washing is a common practice that many women perceive as hygienic. However, vaginal washing has been linked to adverse reproductive health outcomes including increased HIV acquisition risk. The mechanism linking vaginal washing to HIV risk remains unknown, but may be related to increased inflammation caused by intravaginal washing practices. The primary objective of this study is to test the hypothesis that a vaginal washing cessation intervention will reduce concentrations of soluble inflammatory mediators in cervicovaginal fluid and total immune cells in mucosal tissue, reduce cervical epithelial disruption, and increase concentrations of protective vaginal Lactobacillus spp. compared to control.
Eligibility criteria
Qualifiers
Reports vaginal washing beyond the introitus in the past week
Female, aged 18-50
Presence of a cervix
Informed consent obtained and form signed
Disqualifiers
<3 months postpartum or current breastfeeding
Current menstruation (can enroll after menses)
History of bleeding disorder
Visible cervical abnormality requiring evaluation
Trial design
Treatments tested in this trial
- Vaginal washing cessation
Treatment groups
Sponsors and collaborators
University of Washington
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator